Literature DB >> 20178570

In-stent thrombosis after 68 months of implantation inspite of continuous dual antiplatelet therapy: a case report.

Tarun Nagrani1, Medhat Zaher, Sainath Gaddam, George Jabbour, Duccio Baldari, Roberto Baglini, Srinivas Duvvuri.   

Abstract

Lately, there has been an increased incidence of late stent thrombosis; especially following Drug eluting stent (DES) implantation. Several factors are associated with an increased risk of stent thrombosis, including the procedure itself, patient and lesion characteristics, stent design, and premature cessation of anti-platelet drugs. We present a case of late stent thrombosis (LST) following DES implantation after a period of 68 months, making it the longest reported case of LST reported in the literature, despite the use of dual anti-platelet therapy.

Entities:  

Year:  2010        PMID: 20178570      PMCID: PMC2844360          DOI: 10.1186/1757-1626-3-68

Source DB:  PubMed          Journal:  Cases J        ISSN: 1757-1626


  17 in total

1.  Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography.

Authors:  Daisuke Matsumoto; Junya Shite; Toshiro Shinke; Hiromasa Otake; Yusuke Tanino; Daisuke Ogasawara; Takahiro Sawada; Oscar Luis Paredes; Ken-ichi Hirata; Mitsuhiro Yokoyama
Journal:  Eur Heart J       Date:  2006-11-29       Impact factor: 29.983

2.  Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.

Authors:  Matthias Pfisterer; Hans Peter Brunner-La Rocca; Peter T Buser; Peter Rickenbacher; Patrick Hunziker; Christian Mueller; Raban Jeger; Franziska Bader; Stefan Osswald; Christoph Kaiser
Journal:  J Am Coll Cardiol       Date:  2006-11-02       Impact factor: 24.094

3.  Weighing benefits and risks--the FDA's review of prasugrel.

Authors:  Ellis F Unger
Journal:  N Engl J Med       Date:  2009-09-03       Impact factor: 91.245

4.  Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study.

Authors:  Peter Wenaweser; Joost Daemen; Marcel Zwahlen; Ron van Domburg; Peter Jüni; Sophia Vaina; Gerrit Hellige; Keiichi Tsuchida; Cyrill Morger; Eric Boersma; Neville Kukreja; Bernhard Meier; Patrick W Serruys; Stephan Windecker
Journal:  J Am Coll Cardiol       Date:  2008-09-30       Impact factor: 24.094

5.  Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.

Authors:  Bo Lagerqvist; Stefan K James; Ulf Stenestrand; Johan Lindbäck; Tage Nilsson; Lars Wallentin
Journal:  N Engl J Med       Date:  2007-02-12       Impact factor: 91.245

6.  Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

Authors:  Gregg W Stone; Jeffrey W Moses; Stephen G Ellis; Joachim Schofer; Keith D Dawkins; Marie-Claude Morice; Antonio Colombo; Erick Schampaert; Eberhard Grube; Ajay J Kirtane; Donald E Cutlip; Martin Fahy; Stuart J Pocock; Roxana Mehran; Martin B Leon
Journal:  N Engl J Med       Date:  2007-02-12       Impact factor: 91.245

7.  Pathological mechanisms of fatal late coronary stent thrombosis in humans.

Authors:  Andrew Farb; Allen P Burke; Frank D Kolodgie; Renu Virmani
Journal:  Circulation       Date:  2003-09-22       Impact factor: 29.690

8.  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.

Authors:  Gregg W Stone; Stephen G Ellis; David A Cox; James Hermiller; Charles O'Shaughnessy; James Tift Mann; Mark Turco; Ronald Caputo; Patrick Bergin; Joel Greenberg; Jeffrey J Popma; Mary E Russell
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245

9.  Triple antiplatelet therapy vs. dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: an evidence-based approach to answering a clinical query.

Authors:  Inderjeet Singh; Nusrat Shafiq; Promila Pandhi; Srinivas Reddy; Smita Pattanaik; Yashpaul Sharma; Samir Malhotra
Journal:  Br J Clin Pharmacol       Date:  2009-07       Impact factor: 4.335

10.  Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden.

Authors:  Georgios Sianos; Michail I Papafaklis; Joost Daemen; Sofia Vaina; Carlos A van Mieghem; Ron T van Domburg; Lampros K Michalis; Patrick W Serruys
Journal:  J Am Coll Cardiol       Date:  2007-07-30       Impact factor: 24.094

View more
  1 in total

1.  Myocardial bridging is a potential risk factor of very late stent thrombosis of drug eluting stent.

Authors:  Qixia Jiang; Chun Liang; Zonggui Wu
Journal:  Med Sci Monit       Date:  2012-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.